Search results for “Programmed cell death” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,278 patents, we discovered top 274 key players by total patent application. Exelixis, Inc., Regeneron Pharmaceuticals, Inc., Aurigene Discovery Technologies Ltd. are dominant in this area. They take 15.88% of the total patent filing.
California, United States
Patent: 107
New York, United States
Patent: 49
Karnataka, India
Patent: 47
District of Columbia, United States
Patent: 30
Shanghai Shi, China
Patent: 24
Massachusetts, United States
Patent: 22
Idaho, United States
Patent: 21
France
Patent: 20
Massachusetts, United States
Patent: 19
France
Patent: 16
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 49 patents, we discovered top 12 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Eterna Therapeutics LLC, Eucure (Beijing) Biopharma Co., Ltd. are active in this area.
STARTUP
France
Patent: 15
STARTUP
Eterna Therapeutics LLC
New York, United States
Patent: 6
STARTUP
Beijing Shi, China
Patent: 6
STARTUP
Herefordshire, United Kingdom
Patent: 6
STARTUP
California, United States
Patent: 6
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
Zhejiang Sheng, China
Patent: 2
STARTUP
California, United States
Patent: 2
STARTUP
China
Patent: 1
STARTUP
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 657 patents applied in the last 5 years. We discover 233 most active companies in this area. The fast-growing Shanghai Henlius Biotech, Inc., Sanofi SA, Regeneron Pharmaceuticals, Inc. take 9.28% of patent filing during this period.
Shanghai Shi, China
Patent: 22
France
Patent: 20
New York, United States
Patent: 19
New York, United States
Patent: 16
Karnataka, India
Patent: 15
New Jersey, United States
Patent: 15
Centre National De La Recherche Scientif
France
Patent: 14
New York, United States
Patent: 14
Beijing Shi, China
Patent: 14
Cambridgeshire, United Kingdom
Patent: 13
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 657 patents in last 5 years, we discover 168 new entrants. Sanofi SA, Merck Sharp & Dohme Corp., Icahn School of Medicine at Mount Sinai are the most active new entrants in this area.
France
Patent: 20
New Jersey, United States
Patent: 15
New York, United States
Patent: 14
Beijing Shi, China
Patent: 14
Cambridgeshire, United Kingdom
Patent: 13
Minnesota, United States
Patent: 12
Rheinland-Pfalz, Germany
Patent: 11
Beijing Shi, China
Patent: 10
France
Patent: 10
CENTRE COUNTY, France
Patent: 9
Research Institutions
Order by:
Innovation Intensity
With the analysis among 492 patents, we discovered top 96 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Emory University, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 23.37% of the total patent filing.
Massachusetts, United States
Patent: 38
Georgia, United States
Patent: 22
New York, United States
Patent: 14
United States
Patent: 13
France
Patent: 9
CENTRE COUNTY, France
Patent: 9
Connecticut, United States
Patent: 8
Washington, United States
Patent: 8
New South Wales, Australia
Patent: 8
Madrid, Spain
Patent: 8
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: